FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:3235-0104
Expires:02/28/2011
Estimated average burden
hours per response0.5

1. Name and Address of Reporting Person *

Cooperatieve Gilde Healthcare IV U.A.

2. Date of Event Requiring Statement (Month/Day/Year)

01/01/2025

3. Issuer Name and Ticker or Trading Symbol

LAVA Therapeutics NV [LVTX]
(Last)
(First)
(Middle)


STADSPLATEAU 36, 3521 AZ UTRECHT THE NETHERLANDS

4. Relationship of Reporting Person(s) to Issuer

(Check all applicable)

_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

5. If Amendment, Date Original Filed (Month/Day/Year)

(Street)

 
(City)
(State)
(Zip)

6. Individual or Joint/Group Filing

(Check applicable line)

_____ Form Filed by One Reporting Person
__X__ Form Filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)

2. Amount of Securities Beneficially Owned (Instr. 4)

3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)

4. Nature of Indirect Beneficial Ownership (Instr. 5)

Common Shares

5,421,170
D (1)
 


Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)

2. Date Exercisable and Expiration Date (Month/Day/Year)

3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)

4. Conversion or Exercise Price of Derivative Security

5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)

6. Nature of Indirect Beneficial Ownership (Instr. 5)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares





Reporting Owners
Reporting Owner Name / AddressRelationships
Director10% OwnerOfficerOther

Cooperatieve Gilde Healthcare IV U.A.
STADSPLATEAU 36
3521 AZ UTRECHT THE NETHERLANDS
 

  X  

Gilde Healthcare IV Management B.V.
STADSPLATEAU 36
3521 AZ UTRECHT THE NETHERLANDS
 

  X  

Gilde Healthcare Holding B.V.
STADSPLATEAU 36
3521 AZ UTRECHT THE NETHERLANDS
 

  X  

Explanation of Responses:

The shares are held directly by Cooperatieve Gilde Healthcare IV U.A. ("Gilde Healthcare"). Gilde Healthcare IV Management BV ("GHCIVM") manages and advises Gilde Healthcare and is owned by Gilde Healthcare Holding BV ("GHH"). Each of GHCIVM and GHH disclaims beneficial ownership of the shares held by Gilde Healthcare, except to the extent of its respective pecuniary interests therein.



Signatures

/s/ Edwin de Graaf on behalf of Cooperatieve Gilde Healthcare IV U.A.

04/08/2025

/s/ Edwin de Graaf on behalf of Gilde Healthcare Management BV

04/08/2025

/s/ Edwin de Graaf on behalf of Gilde Healthcare Holding BV

04/08/2025
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.